Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gossamer Bio (GOSS) Common Equity: 2022-2024

Historic Common Equity for Gossamer Bio (GOSS) over the last 3 years, with Dec 2024 value amounting to $29.5 million.

  • Gossamer Bio's Common Equity fell 252.09% to -$82.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$82.3 million, marking a year-over-year decrease of 252.09%. This contributed to the annual value of $29.5 million for FY2024, which is 53.02% down from last year.
  • As of FY2024, Gossamer Bio's Common Equity stood at $29.5 million, which was down 53.02% from $62.8 million recorded in FY2023.
  • In the past 5 years, Gossamer Bio's Common Equity registered a high of $62.8 million during FY2023, and its lowest value of $12.1 million during FY2022.
  • In the last 3 years, Gossamer Bio's Common Equity had a median value of $29.5 million in 2024 and averaged $34.8 million.
  • Its Common Equity has fluctuated over the past 5 years, first soared by 419.74% in 2023, then slumped by 53.02% in 2024.
  • Gossamer Bio's Common Equity (Yearly) stood at $12.1 million in 2022, then spiked by 419.74% to $62.8 million in 2023, then crashed by 53.02% to $29.5 million in 2024.